Discovery channel feed – Endpoints News

Discovery channel feed

In search of new way to deliver gene editors, CRISPR pioneer turns to molecular syringes

3 years ago

Deerfield Discovery nets $50M from the state of New York and parent company

3 years ago

Biomea Fusion stock soars on early-stage diabetes data

3 years ago

The venture crew at Mubadala are upping their biotech creation game, taking careful aim at a new frontier in drug development

3 years ago

Celltrion teams up with another Korean biopharma in antibody discovery deal

3 years ago

Chan Zuckerberg Initiative announces Chicago biohub to study tissue inflammation

3 years ago

Construction on Merck's London research hub set to begin in April 2023

3 years ago

In ‘clever’ experiment, scientists use gene editing to treat heart disease in mice

3 years ago

#ASH22 Recap: Leading hematology experts talk top readouts; Fireside chat with Novo Nordisk's Ludovic Helfgott; More

3 years ago

MIT researchers reveal DNA 'Paste' tech behind latest gene editing startup

3 years ago

In 'miraculous' case, doctors treated a baby with a rare genetic disease before she was born

3 years ago

Broad and MIT scientists repurpose hot RNA editing tech as ‘radar’ with uses in cancer and brain research

3 years ago

Using herpes virus vectors, Paul Peter Tak and Carl June team up to solve the CAR-T solid tumor challenge

3 years ago

Antibodies once acted only as protein blockers. Now, scientists are finding new ways to make them protein destroyers

3 years ago

New patent on the prime editing of DNA awarded to Broad Institute's David Liu

3 years ago

Can a special chewing gum slick away Covid-19 from saliva? Penn researchers start clinical trial to find out

3 years ago

The scientist who pioneered KRAS drugs has a new idea about making them more powerful

3 years ago

From Australia, new $173M research center strives to be at the forefront of pandemic drug discovery

3 years ago

Through the lymph nodes it goes — researchers develop a cancer drug that avoids toxicities by skirting the liver

3 years ago

David Liu's lab develops next-gen base editors, small enough to fit into single AAV

3 years ago

RNAi for common diseases? Alnylam plans to forge a path forward, starting with new obesity gene target

3 years ago

'Like a bulletproof vest': Cancer cells make their own kind of collagen. Can piercing through make treatments better?

3 years ago

As ALS patients unite around Amylyx, a new paper hints at potential druggable targets

3 years ago

Doudna research team finds CRISPR-Csm delivery potentially outperforms RNAi, Cas13

3 years ago

First page Previous page 123 4 5 Next page Last page